International collaboration - the doctoral programme in development and regeneration
Our INTRICARE EU Horizon 2020 Marie Curie ITN course held in September 2018, covered some of the latest advances in cardiovascular medicine: from basic to translational research with added value for transferable skills and on the implementation of the sex and gender perspectives in preclinical and clinical research.
In five days with more than 60 participants and more than 36 lecture topics, this course has served not only as an advanced platform for learning, but also presented a unique setting to encourage cooperation and the generation of ideas. Although slightly challenging for the course organizers trying to keep track of everyone involved, the biggest reward has been acknowledged by our international collaborators and students indicating how the concept of ‘internationalization’ should be integrated in research content of educational activities to strengthen international competitiveness while providing an innovative, high-quality diverse course portfolio at university. Read the full article.
The Matera Resolution was drafted in April 2016 by an inaugural group of advocates to create a strategy and develop recommendations to improve the evidence base and applicability of drug trial results to women in real world settings. Recent research evidence and the various activities launched with different stakeholders, including regulatory and funding organizations, journal editors, government agencies, industry and patient sectors are discussed. For further inquiries, please contact: Karolina Kublickiene
The Institute of Gender and Health (IGH)'s mission is to foster research excellence regarding the influence of sex and gender on health and to apply these findings to identify and address pressing health challenges facing men, women, girls, boys and gender-diverse people. Dr Cara Tannebaum is DEVREG's contact at IGH.
Meet a student, get inspired!
CardioRenal Syndrome Analysis (CaReSyAn) is a new project funded by the European Union’s 2020 research and innovation programme, aiming to reduce cardiovascular burden in chronic kidney disease (CKD). The consortium consists of institutes and industry partners across Europe, hosting 11 early stage researchers (ESRs) to learn both scientific and transferable skills throughout the PhD. ESRs also get the opportunity to spend three months in alternative labs to further their knowledge in their dedicated field of research, as well as participate in consortium-run workshops.
One of these positions is held at Karolinska Institutet by Sam Hobson, originally from England, United Kingdom. He will be investigating premature ageing in patients with cardiorenal syndrome, and test the effects of senolytic drugs targeting senescent cells. Throughout the PhD, a number of deliverables are required, including a podcast, annual reports and publications. Please send an email to Sam Hobson directly or Erika Tanos to get Sam’s podcast (to large to upload here), in which he describes his prospective project.